These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3037875)

  • 21. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
    Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
    Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.
    Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB
    Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride.
    Jamaludin A; Mohamad M; Navaratnam V; Yeoh PY; Wernsdorfer WH
    Trop Med Parasitol; 1990 Sep; 41(3):268-72. PubMed ID: 2255843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
    Helsby NA; Ward SA; Edwards G; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1990 Oct; 30(4):593-8. PubMed ID: 2291871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults.
    Watkins WM; Mberu EK; Nevill CG; Ward SA; Breckenridge AM; Koech DK
    Trans R Soc Trop Med Hyg; 1990; 84(4):492-5. PubMed ID: 2091335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
    Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatography of proguanil, cycloguanil and 4-chlorophenylbiguanide using hydrophobic pairing ion and its application to serum assay.
    Moody RR; Selkirk AB; Taylor RB
    J Chromatogr; 1980 Jun; 182(3-4):359-67. PubMed ID: 7391178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil.
    Watkins WM; Chulay JD; Sixsmith DG; Spencer HC; Howells RE
    J Pharm Pharmacol; 1987 Apr; 39(4):261-5. PubMed ID: 2884288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of proguanil and metabolites in small sample volumes of whole blood stored on filter paper by high-performance liquid chromatography.
    Kolawole JA; Taylor RB; Moody RR
    J Chromatogr B Biomed Appl; 1995 Dec; 674(1):149-54. PubMed ID: 8749264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil.
    McGready R; Stepniewska K; Seaton E; Cho T; Cho D; Ginsberg A; Edstein MD; Ashley E; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2003 Oct; 59(7):553-7. PubMed ID: 12955370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorproguanil and chlorcycloguanil concentrations in human plasma and urine after Lapudrine administration.
    Edstein MD; Veenendaal JR
    Trans R Soc Trop Med Hyg; 1987; 81(1):136-9. PubMed ID: 3445299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of Knowledge on OCT1 Variant Activity
    Morse BL; Chen LH; Catlow JT; Fallon JK; Smith PC; Hillgren KM
    Front Pharmacol; 2021; 12():631793. PubMed ID: 33658943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography.
    Taylor RB; Moody RR; Ochekpe NA
    J Chromatogr; 1987 May; 416(2):394-9. PubMed ID: 3611272
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro effect of the antimalarial drug proguanil hydrochloride on viability and DNA damage in human peripheral blood lymphocytes.
    Gajski G; Dinter D; Garaj-Vrhovac V
    Environ Toxicol Pharmacol; 2010 Nov; 30(3):257-63. PubMed ID: 21787658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil.
    Arfeen M; Patel DS; Abbat S; Taxak N; Bharatam PV
    J Comput Chem; 2014 Oct; 35(28):2047-55. PubMed ID: 25196060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excretion of proguanil in human saliva.
    Onyeji CO; Ogunbona FA; Dixon PA
    J Pharm Pharmacol; 1989 Dec; 41(12):872-3. PubMed ID: 2576454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of proguanil and cycloguanil on human lymphocytes in vitro.
    Bygbjerg IC
    Eur J Clin Pharmacol; 1985; 28(3):287-90. PubMed ID: 3874067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose.
    Beermann D; Schaefer HG; Wargenau M; Heibel B; Sturm Y; Kuhlmann J
    Eur J Clin Pharmacol; 1992; 42(3):307-12. PubMed ID: 1315685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous measurement of proguanil and cycloguanil in human plasma by high-performance liquid chromatography.
    Edstein MD
    J Chromatogr; 1986 Jul; 380(1):184-9. PubMed ID: 3745382
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the pharmacokinetics of primaquine.
    Fletcher KA; Evans DA; Gilles HM; Greaves J; Bunnag D; Harinasuta T
    Bull World Health Organ; 1981; 59(3):407-12. PubMed ID: 6976848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.